Owens & Minor ( (OMI) ) has shared an announcement.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Owens & Minor reported a 5% rise in third-quarter revenue to $2.7 billion, driven by robust demand in Patient Direct and Medical Distribution. Despite a GAAP net loss of $13 million, adjusted earnings per share stood at $0.42. The company significantly reduced its debt by nearly $200 million, bolstering its financial position. Looking ahead, Owens & Minor anticipates sequential growth and improved cash flow, aiming for a revenue range of $10.6 to $10.8 billion for 2024.
Find detailed analytics on OMI stock on TipRanks’ Stock Analysis page.
